Clinical Trials Logo

Smoking, Tobacco clinical trials

View clinical trials related to Smoking, Tobacco.

Filter by:

NCT ID: NCT03496077 Completed - Smoking Clinical Trials

Addictive Potential of LCCs in Dual Users

Start date: August 28, 2018
Phase: N/A
Study type: Interventional

This study is about whether or not little cigars and cigarillos cause or maintain addiction, and if flavors, such as fruit, make them more addictive. The purpose of this study is to understand the addiction potential of little cigars and cigarillos compared to cigarettes in young adults who smoke both products. This study will also look at the differences between men and women. In the rest of this form, little cigars or cigarillos will be referred to as LCCs.

NCT ID: NCT03463837 Completed - Tobacco Use Clinical Trials

Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers

Diamond
Start date: March 4, 2018
Phase: N/A
Study type: Interventional

The JUUL 5% Electronic Nicotine Delivery System (ENDS) is being studied as an alternative to combustible cigarette use. This study aims to find out how much nicotine is in the blood and urine of healthy adult subjects after using three JUUL 5% ENDS compared to smoking usual brands of combustible cigarettes and stopping smoking.

NCT ID: NCT03442413 Active, not recruiting - Smoking, Tobacco Clinical Trials

Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction

Start date: June 28, 2018
Phase: Phase 1
Study type: Interventional

Physically healthy adult smokers may be eligible for this study. Volunteers may participate in this study if they are 18 - 65 years old. Subjects will participate in two separate 7-hour PET/CT Scan Sessions (each with 2 hours of actual PET/CT scanning): one following an overnight abstinence and one following two overnights of abstinence. To achieve and confirm two overnights of abstinence, participants will present to the inpatient CHPS the day prior to the scheduled scan and stay overnight. The 2-[18F]-FA PET/CT brain scans will consist of an injection followed by an 7-hour infusion of 2-[18F]-FA. The scan session will begin at approximately 4 hours after the bolus injection. The PET/CT scan will occur in two segments. Starting at approximately 4 hours post bolus and infusion start, we will scan for approximately 90 minutes with a bolus injection of IV nicotine that will occur approximately 15 minutes into the scanning procedure. There will be a break in scanning of approximately 60 minutes, during which subjects will be allowed to get off the scanner and use the restroom, if necessary. The second scan segment will start at approximately 6.5 hours post bolus injection, t. This segment will last approximately 30 minutes. The pre and post nicotine images will be analyzed to evaluate for differences in receptor uptake after the nicotine "challenge". Subjects will have a structural Brain MRI performed within 1 year prior to study enrollment or subjects who have not had a Brain MRI that is deemed acceptable for use for this study will undergo a research Brain MRI after consent.

NCT ID: NCT03405220 Active, not recruiting - Smoking Cessation Clinical Trials

Testing a Self-affirmation Intervention for Use in a Mobile Application

Start date: January 16, 2018
Phase: N/A
Study type: Interventional

The aim of these studies is to adapt the self-affirmation kindness questionnaire for use in a mobile application. Two studies will be conducted to test hypotheses that simplifying and shortening the original questionnaire in systematic ways will result in comparable effectiveness (compared to the original version) in promoting reduced defensive avoidance, less reactance, greater yielding, and higher intentions to quit smoking among a sample of smokers.

NCT ID: NCT03382093 Completed - Anxiety Clinical Trials

Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

Start date: August 23, 2017
Phase: N/A
Study type: Interventional

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

NCT ID: NCT03358953 Completed - Smoking, Tobacco Clinical Trials

The Cardiovascular Impacts of Electronic Cigarettes in Comparison to the Use of Nicotine Replacement Patches

VAPOUR
Start date: December 17, 2016
Phase: N/A
Study type: Interventional

In Scotland tobacco-related illnesses account for in excess of 56,000 hospital admissions and a quarter of deaths each year. The resultant financial impact on NHS Scotland is over £300 million per annum. To minimise the clinical and financial burden of tobacco on national healthcare systems, Scotland's tobacco control strategy aims to create a "tobacco-free" generation by 2034, with the prevalence of smoking in the adult population reduced to ≤5 %. The multifaceted approach focuses upon tobacco prevention, protection and cessation. In relation to smoking cessation, the use of EC has exponentially increased since 2011, and EC are presently the most popular nicotine replacement product used in England. The Public Health England (PHE) Report published in August 2015 advocates the use of EC when other smoking cessation aids have failed.

NCT ID: NCT03353649 Completed - Behavior Clinical Trials

Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking

Start date: December 8, 2017
Phase: N/A
Study type: Interventional

This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

NCT ID: NCT03326128 Terminated - Smoking Cessation Clinical Trials

High Dose Bupropion for Smoking Cessation - Pilot Study

Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

This study aims to investigate the benefit of administering two differing doses of Bupropion (BUP) to smokers to assist with smoking cessation.

NCT ID: NCT03259360 Completed - Smoking Cessation Clinical Trials

A Facebook Intervention for Young Sexual and Gender Minority Smokers

POP
Start date: April 23, 2018
Phase: N/A
Study type: Interventional

The 2-year research plan will test the Put It Out Project (POP) in a pilot randomized trial (N=120) compared to TSP and two historical control conditions. Participants will be young adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 mos.

NCT ID: NCT03251053 Recruiting - Smoking Cessation Clinical Trials

Adverse Airway Effects From Tobacco and E-Cigarettes

Start date: March 28, 2016
Phase: N/A
Study type: Interventional

The purpose of the study conducted at VA Medical Center in Miami is to determine if smoking electronic cigarettes (known as e-cigarettes) that contain nicotine have less negative effects than regular cigarettes on the person's respiratory health. We will assess this by measuring pulmonary function tests, several body molecules and functionality of the airway cells. We will also evaluate how smokers can maintain exclusive electronic cigarettes use. In this study, some people will continue to smoke regular tobacco cigarettes while others will switch to a nicotine-containing electronic cigarette.